Answer
The most frequent adverse reactions to caplacizumab in the TITAN and HERCULES studies were epistaxis (nosebleeds), headache and gingival (gum) bleeding.
Sources for this answer
- Cablivi 10 mg powder and solvent for solution for injectionSANOFI · emc · SmPC §4.8 Undesirable effects · Version 10Document updated
Sources checked